Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Viseu

13 clinical trials in Viseu, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Viseu at a glance
13
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

13 trials in Viseu

Open in trial search

Crohn's disease

Recruiting
Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Regn7508
  • Sponsor:Regeneron Pharmaceuticals Inc.

Dyslipidaemia

Not recruiting
Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Crohn's disease

Not recruiting
Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Vutrisiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Cardiac amyloidosis

Not recruiting
Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Patisiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Crohn's disease

Not recruiting
Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Colitis ulcerative

Not recruiting
Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Viseu

What the registry says about research in the country

01 Gastroenterology Research

Ongoing studies focusing on innovative treatments for inflammatory bowel diseases, with particular emphasis on managing both Crohn's Disease and Ulcerative Colitis. Research aims to evaluate new therapeutic approaches for patients with moderate to severe symptoms.

  • Crohn's Disease Management
  • Ulcerative Colitis Treatments
  • Inflammatory Response Studies

These trials explore both induction and maintenance therapy options to improve patient outcomes.

02 Cardiovascular Medicine

Advanced research into rare cardiac conditions, specifically targeting ATTR Amyloidosis with Cardiomyopathy. Multiple studies are evaluating novel therapeutic agents to enhance functional capacity and quality of life for affected patients.

  • Cardiomyopathy Treatment
  • Amyloidosis Management
  • Cardiac Function Assessment

Research includes comparative studies of different treatment approaches and long-term safety evaluations.

03 Clinical Outcomes

Comprehensive evaluation of therapeutic efficacy across various treatment modalities, focusing on both immediate response and long-term maintenance strategies. Studies incorporate advanced monitoring techniques and safety assessments.

  • Treatment Response Monitoring
  • Long-term Safety Profiles
  • Patient Quality of Life

Research emphasizes measuring clinical remission rates and sustained therapeutic benefits.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.